journal article·2023

Current and promising applications of Hf( iv )-based MOFs in clinical cancer therapy

Xuelin Chen, Minmin Li, Mingzi Lin, Chengyu Lu, Abhinav Kumar, Ying Pan, Jianqiang Liu, Yanqiong Peng

Journal of Materials Chemistry B· Volume 11· Issue 25
Publisher page

Abstract

Cancer is one of the greatest challenges in medical science today as it poses a serious threat to human life. In view of this, myriad of therapeutic strategies are being developed for the treatment of cancer. Despite the use of various therapeutic approaches, they are still insufficient for the treatment of cancer. The rapid advancement of nanotechnology currently offers exciting possibilities for the creation of novel cancer therapy approaches. Metal organic frameworks (MOFs) are emerging multifunctional nanomaterials that find prospective applications in the biomedical field owing to their porosity, large specific surface area, and diversified structures. Amongst varied categories of MOFs, Hf(IV)-based MOFs that have been developed since 2012 and currently have been finding new applications and hence this class of MOFs are gaining immense attention amongst the material and biomaterial chemists. Most importantly, Hf(IV)-MOFs comprising high Z-Hf metal content may be capable of offering new therapeutic options for cancer therapy, nonlinear optics, as fluorescent sensors, and photoresponsive devices. In this review, the progress in Hf(IV)-based MOFs for the treatment of cancer using radiotherapy, chemotherapy, immunotherapy, phototherapeutic techniques, or a combination of two or more of these techniques have been explored. This review also provides insight regarding the current limitations and future prospects of Hf(IV)-MOFs for cancer therapy.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523808, China

Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, and School of Pharmacy, Guangdong Medical University, Guangdong Medical University Key Laboratory of Research and Development of New Medical Materials, Dongguan, 523808, China

Department of Chemistry, Faculty of Science, University of Lucknow, Lucknow 226 007, India

Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China

Funding

Human Resources and Social Security Department of Guangdong Province · National Innovation Talent Promotion Program · Basic and Applied Basic Research Foundation of Guangdong Province · Guangdong Province Introduction of Innovative R&D Team · China Scholarship Council

References (100+)

Show source-provided references
1. Wyld · Nat. Rev. Clin. Oncol. · 2015 · 12 · 11510.1038/nrclinonc.2014.191 ↗
2. Zheng · Nano Res. · 2016 · 9 · 272910.1007/s12274-016-1161-3 ↗
3. Behranvand · Cancer Immunol., Immunother. · 2022 · 71 · 50710.1007/s00262-021-03013-3 ↗
4. Xu · J. Controlled Release · 2023 · 354 · 61510.1016/j.jconrel.2023.01.024 ↗
5. Shang · Adv. Drug Delivery Rev. · 2022 · 185 · 11430810.1016/j.addr.2022.114308 ↗
6. Liu · Theranostics · 2019 · 9 · 279110.7150/thno.34740 ↗
7. Yang · Chem. Sci. · 2018 · 9 · 721010.1039/C8SC02305K ↗
8. Waldman · Nat. Rev. Immunol. · 2020 · 20 · 65110.1038/s41577-020-0306-5 ↗
9. Barbari · Int. J. Mol. Sci. · 2020 · 21 · 110.3390/ijms21145009 ↗
10. Chen · Dalton Trans. · 2023 · 52 · 622610.1039/D3DT00413A ↗
11. Li · J. Mater. Chem. B · 2022 · 10 · 510510.1039/D2TB00742H ↗
12. Liu · J. Mater. Chem. B · 2021 · 9 · 445910.1039/D1TB00453K ↗
13. Zhang · Signal Transduction Targeted Ther. · 2022 · 7 · 25810.1038/s41392-022-01102-y ↗
14. Ye · Dalton Trans. · 2021 · 50 · 1743810.1039/D1DT02814F ↗
15. Ding · J. Colloid Interface Sci. · 2022 · 621 · 18010.1016/j.jcis.2022.04.078 ↗
16. Tan · J. Solid State Chem. · 2022 · 314 · 12335210.1016/j.jssc.2022.123352 ↗
17. He · Chem. Rev. · 2015 · 115 · 1107910.1021/acs.chemrev.5b00125 ↗
18. Liu · Inorg. Chem. · 2014 · 53 · 191610.1021/ic402194c ↗
19. Vellingiri · Nano Res. · 2016 · 9 · 318110.1007/s12274-016-1230-7 ↗
20. He · Nano Res. · 2016 · 9 · 185610.1007/s12274-016-1078-x ↗
21. Li · Nat. Rev. Clin. Oncol. · 2020 · 17 · 65710.1038/s41571-020-0410-2 ↗
22. Hu · Nanoscale · 2018 · 10 · 2265710.1039/C8NR07627H ↗
23. Fang · J. Mater. Chem. B · 2019 · 7 · 193310.1039/C8TB03331E ↗
24. Fang · Int. J. Biol. Macromol. · 2020 · 154 · 73210.1016/j.ijbiomac.2020.03.139 ↗
25. Fang · Int. J. Pharm. · 2020 · 591 · 11999010.1016/j.ijpharm.2020.119990 ↗
26. Pelmenschikov · J. Am. Chem. Soc. · 2023 · 145 · 427910.1021/jacs.2c10885 ↗
27. Zhou · Nanomaterials · 2022 · 12 · 405810.3390/nano12224058 ↗
28. Wei · Mater. Sci. Eng., C · 2019 · 104 · 10989110.1016/j.msec.2019.109891 ↗
29. Xing · Chem. Eng. J. · 2023 · 464 · 14263210.1016/j.cej.2023.142632 ↗
30. Shang · Biomater. Sci. · 2020 · 8 · 524110.1039/D0BM01158D ↗
31. Wu · Acta Pharm. Sin. B · 2021 · 11 · 236210.1016/j.apsb.2021.03.019 ↗
32. Wang · Biomaterials · 2020 · 230 · 11961910.1016/j.biomaterials.2019.119619 ↗
33. Lawson · ACS Appl. Mater. Interfaces · 2021 · 13 · 700410.1021/acsami.1c01089 ↗
34. Qin · J. Mol. Struct. · 2023 · 1282 · 13522010.1016/j.molstruc.2023.135220 ↗
35. Dong · J. Solid State Chem. · 2023 · 318 · 12371310.1016/j.jssc.2022.123713 ↗
36. Yan · J. Solid State Chem. · 2022 · 316 · 12356610.1016/j.jssc.2022.123566 ↗
37. Qin · J. Solid State Chem. · 2022 · 312 · 12317510.1016/j.jssc.2022.123175 ↗
38. Li · Appl. Organomet. Chem. · 2023 · 37 · e692010.1002/aoc.6920 ↗
39. Dong · J. Solid State Chem. · 2023 · 318 · 12371310.1016/j.jssc.2022.123713 ↗
40. Qin · J. Mol. Struct. · 2023 · 1282 · 13522010.1016/j.molstruc.2023.135220 ↗
41. Ke · J. Colloid Interface Sci. · 2023 · 642 · 6110.1016/j.jcis.2023.03.137 ↗
42. Ranjbar · Drug Des., Dev. Ther. · 2018 · 12 · 263510.2147/DDDT.S173324 ↗
43. Chen · Dalton Trans. · 2023 · 52 · 622610.1039/D3DT00413A ↗
44. Xu · J. Controlled Release · 2023 · 354 · 61510.1016/j.jconrel.2023.01.024 ↗
45. Au-Duong · Mater. Sci. Eng., C · 2017 · 76 · 47710.1016/j.msec.2017.03.114 ↗
46. Pinto · Acta Biomater. · 2017 · 51 · 6610.1016/j.actbio.2017.01.039 ↗
47. Wan · Biomaterials · 2018 · 185 · 5110.1016/j.biomaterials.2018.09.004 ↗
48. Chen · Chem. Commun. · 2020 · 56 · 1062110.1039/D0CC03245J ↗
49. Koukourakis · J. Clin. Oncol. · 2006 · 24 · 72710.1200/JCO.2005.02.7474 ↗
50. Yuan · ACS Cent. Sci. · 2018 · 4 · 44010.1021/acscentsci.8b00073 ↗
51. Lan · Angew. Chem., Int. Ed. · 2017 · 56 · 1210210.1002/anie.201704828 ↗
52. Jakobsen · Phys. Rev. B: Condens. Matter Mater. Phys. · 2012 · 86 · 12542910.1103/PhysRevB.86.125429 ↗
53. Feng · Inorg. Chem. · 2013 · 52 · 1266110.1021/ic4018536 ↗
54. Hu · Inorg. Chem. · 2016 · 55 · 113410.1021/acs.inorgchem.5b02312 ↗
55. Lu · J. Am. Chem. Soc. · 2015 · 137 · 760010.1021/jacs.5b04069 ↗
56. Garcia-Garcia · Isr. J. Chem. · 2018 · 58 · 106210.1002/ijch.201800099 ↗
57. Maggiorella · Future Oncol. · 2012 · 8 · 116710.2217/fon.12.96 ↗
58. Jayaraman · Mater. Express · 2014 · 4 · 37510.1166/mex.2014.1190 ↗
59. Yuan · ACS Cent. Sci. · 2018 · 4 · 44010.1021/acscentsci.8b00073 ↗
60. Gajewski · Nat. Immunol. · 2013 · 14 · 101410.1038/ni.2703 ↗
61. Hu · Chem. Soc. Rev. · 2021 · 50 · 462910.1039/D0CS00920B ↗
62. Zhang · Adv. Sci. · 2019 · 6 · 190053010.1002/advs.201900530 ↗
63. Lan · J. Am. Chem. Soc. · 2019 · 141 · 685910.1021/jacs.9b03029 ↗
64. Luo · J. Am. Chem. Soc. · 2021 · 143 · 1351910.1021/jacs.1c07379 ↗
65. Zhou · ACS Omega · 2022 · 7 · 1202110.1021/acsomega.2c00223 ↗
66. Yang · NPG Asia Mater. · 2017 · 9 · e34410.1038/am.2016.205 ↗
67. Liu · Adv. Funct. Mater. · 2017 · 27 · 160592610.1002/adfm.201605926 ↗
68. Gong · ACS Nano · 2020 · 14 · 303210.1021/acsnano.9b07898 ↗
69. Sang · Adv. Sci. · 2020 · 8 · 200333810.1002/advs.202003338 ↗
70. Zheng · Chem. Mater. · 2017 · 29 · 237410.1021/acs.chemmater.7b00228 ↗
71. Jiang · Nano Today · 2020 · 34 · 10091010.1016/j.nantod.2020.100910 ↗
72. Lu · J. Am. Chem. Soc. · 2014 · 136 · 1671210.1021/ja508679h ↗
73. Zhou · Inorg. Chem. · 2022 · 61 · 464710.1021/acs.inorgchem.1c03649 ↗
74. Zhang · Chem. Sci. · 2019 · 10 · 845510.1039/C9SC03080H ↗
75. Luo · J. Am. Chem. Soc. · 2022 · 144 · 524110.1021/jacs.2c00384 ↗
76. Chen · Chem. Sci. · 2019 · 10 · 577310.1039/C9SC00747D ↗
77. Chao · ACS Nano · 2018 · 8 · 751910.1021/acsnano.8b02400 ↗
78. Zheng · Chem. Mater. · 2018 · 30 · 8667
79. Zheng · Biomaterials · 2020 · 235 · 11979210.1016/j.biomaterials.2020.119792 ↗
80. Liu · Biomaterials · 2016 · 97 · 110.1016/j.biomaterials.2016.04.034 ↗
81. Neifeld · Nano Res. · 2019 · 12 · 300310.1007/s12274-019-2544-z ↗
82. Liu · Adv. Funct. Mater. · 2017 · 27 · 170382
83. DuRoss · Cancer lett. · 2021 · 500 · 20810.1016/j.canlet.2020.11.021 ↗
84. Liu · ACS Appl. Mater, Interfaces · 2018 · 10 · 2463810.1021/acsami.8b07570 ↗
85. Ni · Chem. Sci. · 2020 · 11 · 764110.1039/D0SC01949F ↗
86. Ni · Nat. Commun. · 2018 · 9 · 235110.1038/s41467-018-04703-w ↗
87. Ni · Chem. Sci. · 2020 · 11 · 764110.1039/D0SC01949F ↗
88. Ni · J. Am. Chem. Soc. · 2022 · 144 · 1590710.1021/jacs.2c07990 ↗
89. Ni · Matter · 2019 · 1 · 133110.1016/j.matt.2019.06.007 ↗
90. Liu · Adv. Mater. · 2021 · 33 · e200788810.1002/adma.202007888 ↗
91. Bao · Int. J. Nanomedicine · 2020 · 15 · 768710.2147/IJN.S267321 ↗
92. Ni · Nat. Commun. · 2018 · 9 · 432110.1038/s41467-018-06655-7 ↗
93. G.Lan , K.Ni , R.Xu , K.Lu , Z.Lin , C.Chan and W.Lin , Angew. Chem., Int. Ed. , 2017 , 56, 12102–12106
94. Neufeld · Chem · 2021 · 27 · 322910.1002/chem.202003523 ↗
95. Huang · ACS Nano · 2019 · 13 · 1342
96. Hu · Chem. Soc. Rev. · 2021 · 5 · 462910.1039/D0CS00920B ↗
97. Yusuf · ACS Omega · 2022 · 7 · 4450710.1021/acsomega.2c05310 ↗
98. Wang · J. Am. Chem. Soc. · 2014 · 136 · 617110.1021/ja500671h ↗
99. Nguyen · J. Catal. · 2019 · 374 · 11010.1016/j.jcat.2019.04.023 ↗
100. Bon · Cryst. Growth Des. · 2013 · 13 · 123110.1021/cg301691d ↗